Literature DB >> 29770314

Factors leading to pancreatic resection in patients with pancreatic cancer: a national perspective.

David T Pointer1, Zaid Al-Qurayshi1, John B Hamner1, Douglas P Slakey1, Emad Kandil1.   

Abstract

BACKGROUND: Resection is the only option for potential cure in pancreatic cancer. Patients admitted for resection may have the procedure deferred during their hospitalization. We aim to identify factors that lead pancreatic cancer patients to undergo resection.
METHODS: An analysis utilizing the Nationwide Inpatient Sample (NIS) database, 2003-2009. Study population included adults (≥18 years) with pancreatic cancer who underwent either pancreatic resection or other interventions. Surgeon volume classified based on the median into low and high-volume surgeon.
RESULTS: Eleven thousand three hundred and sixty-five patients were included; 68.0% underwent pancreatic resection, while 32.0% had other interventions. The majority of patients resected were <60 years old, female, with higher annual household income (P<0.05 for all). Patients with Medicaid coverage and comorbidity scores ≥2 were least likely to undergo pancreatic resection. Resection was more likely for high-volume surgeons, high-volume hospitals and teaching hospitals (P<0.05 for all). Those managed by high-volume surgeons were at a lower risk of postoperative complications, lower mortality, shorter hospital stay, and lower healthcare costs (P<0.05 for all).
CONCLUSIONS: Patients' insurance type and economic status are significantly associated with their ability to achieve pancreatic resection. Surgeon experience and hospital volumes were also significantly associated with pancreatic resection, clinical and economic outcomes.

Entities:  

Keywords:  Nationwide Inpatient Sample (NIS); Pancreatic cancer; pancreatic resection; patient factors and pancreatic resection; surgeon volume

Year:  2018        PMID: 29770314      PMCID: PMC5938269          DOI: 10.21037/gs.2017.12.04

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  27 in total

1.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

Review 2.  Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands.

Authors:  N Tjarda van Heek; Koert F D Kuhlmann; Rob J Scholten; Steve M M de Castro; Olivier R C Busch; Thomas M van Gulik; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

3.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

4.  The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer.

Authors:  Edward L Hannan; Mark Radzyner; David Rubin; James Dougherty; Murray F Brennan
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

5.  Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.

Authors:  Jason A Zell; Jessica M Rhee; Argyrios Ziogas; Steven M Lipkin; Hoda Anton-Culver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

6.  Physician and hospital factors associated with mortality of surgical patients.

Authors:  J V Kelly; F J Hellinger
Journal:  Med Care       Date:  1986-09       Impact factor: 2.983

7.  Hospital volume and operative mortality in cancer surgery: a national study.

Authors:  Emily V A Finlayson; Philip P Goodney; John D Birkmeyer
Journal:  Arch Surg       Date:  2003-07

8.  Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients.

Authors:  Jonathan E Lim; Michael W Chien; Craig C Earle
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

9.  Total pancreatectomy: a national study.

Authors:  Melissa M Murphy; William J Knaus; Sing Chau Ng; Joshua S Hill; James T McPhee; Shimul A Shah; Jennifer F Tseng
Journal:  HPB (Oxford)       Date:  2009-09       Impact factor: 3.647

10.  Patient and hospital characteristics on the variance of perioperative outcomes for pancreatic resection in the United States: a plea for outcome-based and not volume-based referral guidelines.

Authors:  Swee H Teh; Brian S Diggs; Clifford W Deveney; Brett C Sheppard
Journal:  Arch Surg       Date:  2009-08
View more
  1 in total

1.  The Ras-ERK signaling pathway regulates acetylated activating transcription factor 2 via p300 in pancreatic cancer cells.

Authors:  Mu Li; Shao-Wei Song; Yang Ge; Jun-Yi Jin; Xiao-Ying Li; Xiao-Dong Tan
Journal:  Ann Transl Med       Date:  2020-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.